<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00719056</url>
  </required_header>
  <id_info>
    <org_study_id>TEICO01</org_study_id>
    <nct_id>NCT00719056</nct_id>
  </id_info>
  <brief_title>Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty</brief_title>
  <official_title>Efficacy of Teicoplanin for the Prevention of Surgical Site Infections After Total Hip or Knee Arthroplasty: A Prospective, Open-Label Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KAT Hospital of Athens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Athens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, open-label, randomized clinical trial where patients were administered
      prophylaxis for total hip or knee arthroplasty either with teicoplanin or with other
      antibiotics. The study is aiming to evaluate any differences between these two different
      strategies of antimicrobial prophylaxis in the occurrence of surgical site infections
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, open-label, randomized clinical trial where patients were administered
      prophylaxis for total hip or knee arthroplasty either with a single dose of teicoplanin or
      with multiple doses of other antibiotics according to the habits of the attending physicians
      aiming to evaluate any differences between these two different strategies of antimicrobial
      prophylaxis in the occurrence of surgical site infections
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the efficacy of single dose teicoplanin compared with comparator agents in the prevention of surgical site infections after total hip or knee arthroplasty.</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the efficacy of single dose teicoplanin compared with comparator agents in the separate prevention of superficial or deep surgical site infections after total hip or knee arthroplasty.</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">616</enrollment>
  <condition>Total Hip and Knee Arthroplasties</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgical chemoprophylaxis of one dose of teicoplanin upon introduction of anesthesia for total hip or knee arthroplasty.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical chemoprophylaxis with multiple dose of other antimicrobials for up to six consecutive days for total hip or knee arthroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Teicoplanin</intervention_name>
    <description>The selected dose was 10mg/kg and it was given intravenously by a catheter inserted under aseptic conditions in a forearm vein within 15 minutes; it was diluted in one 5% glucose solution of a 50 ml final volume</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Glycopeptide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>β-lactams or ciprofloxacin</intervention_name>
    <description>Multiple doses for up to six consecutive days</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Cephalosporins or ciprofloxacin or penicillincs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted for total hip arthroplasty

          -  Patients admitted for total knee arthroplasty

        Exclusion Criteria:

          -  Revision arthroplasty

          -  History of any infection within the preceding two months

          -  History of an operation in the same hip or knee for other causes

          -  Known history of allergy to the studied drug

          -  Pregnancy or lactation

          -  Any antibiotic therapy in the week before operation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen Giamarellou, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>4th Department of Internal Medicine, University of Athens, Medical School, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amyntas Varvaroussis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>3rd Department of Orthopedics, KAT Hospital, Maroussi, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Panagiotis Papadelis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>2nd Department of Orthopedics, KAT Hospital, Maroussi, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vassilios Nikolaidis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>4th Department of Orthopedics, KAT Hospital, Maroussi, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonios Papadopoulos, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>4th Department of Internal Medicine, University of Athens, Medical School, Greece</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>2nd Department of Orthopedics, KAT Hospital</name>
      <address>
        <city>Maroussi</city>
        <state>Athens</state>
        <zip>14527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>3rd Department of Orthopedics, KAT Hospital</name>
      <address>
        <city>Maroussi</city>
        <state>Athens</state>
        <zip>14527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>4th Department of Orthopedics, KAT Hospital</name>
      <address>
        <city>Maroussi</city>
        <state>Athens</state>
        <zip>14527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Soriano A, Popescu D, García S, Bori G, Martínez JA, Balasso V, Marco F, Almela M, Mensa J. Usefulness of teicoplanin for preventing methicillin-resistant Staphylococcus aureus infections in orthopedic surgery. Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):35-8.</citation>
    <PMID>16424973</PMID>
  </reference>
  <reference>
    <citation>Wilson AP, Grüneberg RN, Neu H. Dosage recommendations for teicoplanin. J Antimicrob Chemother. 1993 Dec;32(6):792-6. Review.</citation>
    <PMID>8144419</PMID>
  </reference>
  <reference>
    <citation>Nehrer S, Thalhammer F, Schwameis E, Breyer S, Kotz R. Teicoplanin in the prevention of infection in total hip replacement. Arch Orthop Trauma Surg. 1998;118(1-2):32-6.</citation>
    <PMID>9833102</PMID>
  </reference>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2008</study_first_submitted>
  <study_first_submitted_qc>July 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2008</study_first_posted>
  <last_update_submitted>July 18, 2008</last_update_submitted>
  <last_update_submitted_qc>July 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2008</last_update_posted>
  <responsible_party>
    <organization>University of Athens, Medical School, Greece</organization>
  </responsible_party>
  <keyword>teicoplanin</keyword>
  <keyword>prophylaxis</keyword>
  <keyword>arthroplasty</keyword>
  <keyword>surgical site infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Cephalosporins</mesh_term>
    <mesh_term>Teicoplanin</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

